Literature DB >> 1272073

Nucleation and growth of brushite and calcium oxalate in urine of stone-formers.

C Y Pak, K Holt.   

Abstract

The physicochemical factors involved in the formation of calcium-containing renal stones have been elucidated previously and some of the techniques for their quantitation are currently available. Accordingly, urinary activity product ratio (state of saturation), formation product ratio (limit of metastability), and crystal growth of brushite and calcium oxalate in 24-hr urine samples were compared between a control group without stones and stone-forming groups composed of patients with absorptive hypercalciuria, normocalciuric nephrolithiasis, and primary hyperparathyroidism. The activity product ratios of brushite and calcium oxalate were significantly elevated in stone-forming groups, largely because of the high renal excretion of calcium. The formation product ratios were reduced in most stone-forming groups, and the crystal growth was increased in the group with primary hyperparathyroidism. Thus, the physicochemical environment of urine in stone-forming groups was favorable to the nucleation of the nidi of brushite and calcium oxalate; in primary hyperparathyroidism, it may be conducive to the subsequent growth of nidi as well.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1272073     DOI: 10.1016/0026-0495(76)90064-0

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  26 in total

1.  The risk of nephrolithiasis with oral calcium supplementation.

Authors:  J D Ringe
Journal:  Calcif Tissue Int       Date:  1991-02       Impact factor: 4.333

Review 2.  Supersaturation and renal precipitation: the key to stone formation?

Authors:  John P Kavanagh
Journal:  Urol Res       Date:  2006-01-26

3.  Urinary sodium and calcium in various dog models and relationship to endogenous plasma glucagon.

Authors:  C Bornhof; P O Schwille
Journal:  Urol Res       Date:  1977

4.  [Evaluation of renal cyclic adenosine monophosphate, serum parathyroid hormone and phosphate reabsorption in recurrent calcium urolithiasis, healthy controls and hyperparathyroidism (author's transl)].

Authors:  P O Schwille; C Bornhof; R Thun; D Scholz; R Bötticher; W Schellerer; A Sigel
Journal:  Klin Wochenschr       Date:  1978-06-15

5.  Studies of urinary calcium oxalate crystallization in clinical research.

Authors:  J M Baumann
Journal:  Urol Res       Date:  1989

6.  How reliable are the measurements of crystallization conditions in urine?

Authors:  J M Baumann
Journal:  Urol Res       Date:  1988

7.  Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.

Authors:  Steeve Doizi; John R Poindexter; Margaret S Pearle; Francisco Blanco; Orson W Moe; Khashayar Sakhaee; Naim M Maalouf
Journal:  J Urol       Date:  2018-07-20       Impact factor: 7.450

8.  Urine saturation with calcium salts in normal subjects and idiopathic calcium stone-formers estimated by an improved computer model system.

Authors:  M Marangella; P G Daniele; M Ronzani; S Sonego; F Linari
Journal:  Urol Res       Date:  1985

9.  Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition.

Authors:  Jack G Kleinman; Laura J Alatalo; Ann M Beshensky; Jeffrey A Wesson
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

10.  Inhibition of calcium oxalate crystallization by urinary macromolecules.

Authors:  H Bek-Jensen; H G Tiselius
Journal:  Urol Res       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.